Education
Read all articles form Edition 2 of the ESMO Perspectives.
All articles
Collaboration
Read all articles from Edition 6 of the ESMO Perspectives.
Challenges
Read all articles from Edition 7 of the ESMO Perspectives.
Boundaries
Read all articles from Edition 8 of the ESMO Perspectives.
Could the daunting biology of small-cell lung cancer provide the key to elucidating drug resistance?
At ELCC 2021, Prof. Fiona Blackhall sees hope for improving patients’ poor prognoses on the horizon
The “holy grail” of lung cancer research: bring the immune system into every tumour
With multiple new therapies available, Prof. Johan Vansteenkiste says the search is on for biomarkers to better match patients to treatments
Cancer care in war zones: what have we learnt?
In recent conflicts, good response to the health needs of refugees with cancer in receiving countries is consequence of an analysis of local cancer centres capacity and special measures to avoid fragmented care
Cancer treatment – how to wisely reduce its burden? A new ESMO tool to guide de-intensification
ESMO developed a classification to assess the risk-benefit ratio of treatment intensity modulation by a three-tiered approach
How to discuss cancer treatment modulation with patients?
Experience in breast cancer shows that treatment de-intensification must follow robust evidence, but also values and preferences to generate acceptance
Doctor-Patient
A virtual space where to discuss the how the doctor-patient relationship is evolving in oncology. Prof. Alberto Sobrero has been the Head of the Medical Oncology Unit at Ospedale San Martino in Genova, Italy, since 2001.
On target
A virtual space where to discuss the latest achievements in precision oncology. Dr Garralda directs the Research Unit for Molecular Therapy of Cancer (UITM) – CaixaResearch, at Vall d' Hebron Institute of Oncology (VHIO), Barcelona, Spain. She is also Principal Investigator of VHIO’s Early Clinical Drug Development Group.
(Un)Sustainable
A virtual space where to reflect on sustainability in cancer care. Dr Trapani is a fellow at the Dana Farber Cancer Institute, Boston, US. He has collaborated with the World Health Organization as a consultant of the cancer control team for two years.
Ukraine: what help for refugees with breast cancer?
In neighbouring countries, oncologists are seeing a growing number of female refugees with breast cancer whose treatment may have started before they left Ukraine and urgently needs to be continued for good outcomes to be achieved.
De-escalation of cancer treatments may be key to sustainability in oncology
Treating patients at reduced doses could contribute to a more efficient allocation of healthcare resources and improve access to costly treatments around the world, but implementation of de-escalation in routine practice requires reliable and cost-effective tools to safely tailor therapy to patients
Can academic oncology compete with the career prospects offered by the pharma industry?
Moving back and forth across academic and corporate positions has become increasingly common for oncologists in search of new opportunities